Detalles de la búsqueda
1.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med;
388(23): 2145-2158, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36972026
2.
Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Gynecol Oncol;
183: 78-84, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554477
3.
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Gynecol Oncol;
182: 51-56, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262238
4.
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Gynecol Oncol;
177: 46-52, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639902
5.
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Gynecol Oncol;
173: 15-21, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37037083
6.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Gynecol Oncol;
178: 14-22, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741201
7.
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Gynecol Oncol;
177: 20-31, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37625235
8.
Postoperative venous thromboembolism risk stratification in patients with uterine cancer.
Am J Obstet Gynecol;
228(5): 555.e1-555.e8, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36574873
9.
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer.
Am J Obstet Gynecol;
228(1): 59.e1-59.e13, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35931127
10.
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Int J Gynecol Cancer;
33(4): 562-570, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564099
11.
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?
Gynecol Oncol;
167(2): 174-180, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36154763
12.
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study.
Gynecol Oncol;
167(3): 429-435, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36244828
13.
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Gynecol Oncol;
164(3): 481-491, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063278
14.
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
Gynecol Oncol;
166(3): 410-416, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835612
15.
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?
Oncologist;
26(12): 1044-1051, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402130
16.
Standing on the shoulders of giants: Mentorship advice from leaders in the field.
Gynecol Oncol;
161(2): 339-341, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516530
17.
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer.
Gynecol Oncol;
162(3): 619-625, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272090
18.
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.
Gynecol Oncol;
162(1): 203-209, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722417
19.
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
Am J Obstet Gynecol;
222(1): 60.e1-60.e7, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31401259
20.
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.
Gynecol Oncol;
153(2): 255-258, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30718123